MAPK1+KRAS(G12C) NanoBRET Target Engagement Intracellular Kinase Assay for screening of compounds binding to the target.
MAPK1+KRAS(G12C)
MAPK1+KRAS(G12C)
ERK2; ERT1; P42MAPK; PRKM1
HEK293 human epithelial cell line from ATCC
384-well plate format using Promega’s NanoBRET TE Intracellular Kinase Assay
HEK293 cells transiently co-expressing NanoLuc-MAPK1 Fusion Vector and KRAS(G12C) Vector were seeded into the wells of 384-well plates. The cells were pre-treated with the NanoBRET Tracer K-5 and then treated with reference compound CTx-0294885 for 1 hour. The BRET signal was measured on an Envision 2104 Multilabel Reader. IC50 value was calculated and IC50 curve was plotted using the GraphPad Prism program based on a sigmoidal dose response equation.
Binding of compound to target kinase
Compounds | IC50 (M) |
---|---|
CTx-0294885 | 6.180e-007 |
Malvern, PA, USA
More information can be found on our website NanoBRET Target Engagement Intracellular Kinase Assay Services
Reference compound IC50 for MAPK1+KRAS(G12C)